David Raben
- Otorhinolaryngology top 0.02%
- Head and Neck Cancer Studies 76
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 23
- Cancer Diagnosis and Treatment 16
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations 58
- Prostate Cancer Diagnosis and Treatment 22
- Prostate Cancer Treatment and Research 19
- Cancer Research top 0.5%
- Radiation top 0.5%
- Advanced Radiotherapy Techniques 30
-
- Colorectal and Anal Carcinomas 16
- Co-authors
- Robert L. FerrisAthanassios ArgirisMichalis V. KaramouzisPaul M. HarariJ. GiraltJames A. BonnerJosé BaselgaChristopher U. Jones
- Journals
- International Journal of Radiation Oncology*Biology*Physics (49 papers)Journal of Clinical Oncology (24 papers)Clinical Cancer Research (14 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
David Raben
230 papers receiving 14.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Otorhinolaryngology 5.2k
- Oncology 6.8k
- Pulmonary and Respiratory Medicine 5.6k
- Cancer Research 1.8k
- Radiation 892
Countries citing papers authored by David Raben
This map shows the geographic impact of David Raben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Raben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Raben more than expected).
Fields of papers citing papers by David Raben
This network shows the impact of papers produced by David Raben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Raben. The network helps show where David Raben may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Raben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapiesbreakdown → | 2025 | 21 |
| 2 | 2020 | 16 | |
| 3 | 2020 | 25 | |
| 4 | 2019 | 38 | |
| 5 | 2019 | 36 | |
| 6 | 2018 | 27 | |
| 7 | 2018 | 68 | |
| 8 | 2018 | 23 | |
| 9 | 2018 | 209 | |
| 10 | 2018 | 9 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 44 | |
| 13 | 2015 | 150 | |
| 14 | 2014 | 59 | |
| 15 | Back to the future: a proton pro/con. | 2011 | 1 |
| 16 | 2010 | 10 | |
| 17 | Abstract #3989: Combined Resveratrol and radiation therapy in head and neck cancer | 2009 | 2 |
| 18 | 2008 | 14 | |
| 19 | 1993 | 61 | |
| 20 | 1990 | 47 |
About David Raben
David Raben is a scholar working on Otorhinolaryngology, Oncology and Radiation, having authored 236 papers that have together received 15.2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (76 papers), Lung Cancer Treatments and Mutations (58 papers), Advanced Radiotherapy Techniques (30 papers), Cancer Immunotherapy and Biomarkers (23 papers), Prostate Cancer Diagnosis and Treatment (22 papers), Prostate Cancer Treatment and Research (19 papers), Colorectal and Anal Carcinomas (16 papers) and Cancer Diagnosis and Treatment (16 papers). The work is most often cited by research in Otorhinolaryngology (5.2k citations), Oncology (6.8k citations) and Pulmonary and Respiratory Medicine (5.6k citations). David Raben has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Robert L. Ferris, Athanassios Argiris, Michalis V. Karamouzis, Paul M. Harari, J. Giralt, James A. Bonner, José Baselga, Christopher U. Jones, Roger B. Cohen and Ranjan Sur. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.